Background: Chronic HBV infection has a continuous effect on blood sugar and blood phospholipid metabolism. Metabolic syndrome (MS) and insulin resistance (IR) are the main risk factor leading to diabetes and cardiovascular disease. At present, the relationship between chronic HBV infection and MS was still controversial. Objective: To explore the correlation between hepatitis B virus (HBV) infection status, level of surface antigen-antibody and phospholipid metabolism, insulin resistance (IR). Methods: A retrospective analysis was performed on the clinical data of 423 patients who underwent hepatitis B markers test in the hospital from January 2017 to June 2019. Among them, there were 95 cases with positive hepatitis B surface antigen (HBsAg) in the HBV infection positive group and 328 cases with negative HBsAg in the HBV infection negative group. The serum phospholipid fatty acid maps and IR related indexes were compared between the two groups. The correlation between the level of HBsAg antibody and phospholipid fatty acid maps, IR related indexes were analyzed by Spearman analysis. Results: The levels of saturated fatty acid (SFA) and u-6/u-3 polyunsaturated fatty acid (PUFA) in the HBV infection positive group were higher than those in the HBV infection negative group, while n-6PUFA, n-3PUFA, PUFA, and PUFA/SFA were all lower than those in HBV infection negative group (P<0.05). The levels of fasting blood glucose (FBG) and insulin resistance index (HOMA-IR) in the HBV infection positive group were higher than those in the HBV infection negative group, while fasting insulin (FINS) and islet sensitivity index (ISI) were lower than those in HBV infection negative group (P<0.05). Spearman correlation analysis showed that HBeAg level was positively correlated with SFA, n-6/n-3 PUFA, FBG and HOMA-IR (r=0.381, 0.369, 0.516, 0.453, P<0.001), while negatively correlated with n-3 PUFA, n-6 PUFA, PUFA, PUFA/SFA, FINS and ISI (r=-0.322, -0.306, -0.467, -0.482, -0.465, -0.356, P<0.001). Conclusion: HBV infection may cause changes in the composition of serum phospholipid fatty acid and IR.
Published in | American Journal of Internal Medicine (Volume 9, Issue 2) |
DOI | 10.11648/j.ajim.20210902.17 |
Page(s) | 91-95 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Hepatitis B Virus, Hepatitis B Surface Antigen, Phospholipid Fatty Acid, Insulin Resistance
[1] | Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study [J]. Lancet Gastroenterol Hepatol, 2018, 3 (6): 383-403. |
[2] | Indolfi G, Easterbrook P, Dusheiko G, et al. Hepatitis B virus infection in children and adolescents [J]. Lancet Gastroenterol Hepatol, 2019, 4 (6): 466-476. |
[3] | Chen XL, Han YD, Wang H. Relations of hepatic steatosis with liver functions, inflammations, glucolipid metabolism in chronic hepatitis B patients [J]. Eur Rev Med Pharmacol Sci, 2018, 22 (17): 5640-5646. |
[4] | McCracken E, Monaghan M, Sreenivasan S. Pathophysiology of the metabolic syndrome [J]. Clin Dermatol, 2018, 36 (1): 14-20. |
[5] | Mendrick DL, Diehl AM, Topor LS, et al. Metabolic syndrome and associated diseases: from the bench to the clinic [J]. Toxicol Sci, 2018, 162 (1): 36-42. |
[6] | Gluvic Z, Zaric B, Resanovic I, et al. Link between metabolic syndrome and insulin resistance [J]. Curr Vasc Pharmacol, 2017, 15 (1): 30-39. |
[7] | Choi JS, Han KJ, Lee S, et al. Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome in Korean adult men [J]. J Epidemiol, 2015, 25 (1): 74-79. |
[8] | Jinjuvadia R, Liangpunsakul S. Association between metabolic syndrome and its individual components with viral hepatitis B [J]. Am J Med Sci, 2014, 347 (1): 23-27. |
[9] | Zhou Y, Cui Y, Deng H, et al. Association between hepatitis B virus infection and metabolic syndrome: a retrospective cohort study in Shanghai, China [J]. BMC Public Health, 2014, 516 (14): 1-6. |
[10] | Cai S, Ou Z, Liu D, et al. Risk factors associated with liver steatosis and fibrosis in chronic hepatitis B patient with component of metabolic syndrome [J]. United European Gastroenterol J, 2018, 6 (4): 558-566. |
[11] | Chinese Society of infectious and parasitic diseases and Chinese Society of Liver Diseases. Viral Hepatitis Prevention and Treatment Manual [J], CHINESE JOURNAL OF HEPATOLOGY, 2000, 8 (6): 324-328. |
[12] | Li Fu L, Li B, Liu Y, et al. A Comparative Study of Serum Fatty Acid in Patients with Psoriasis Vulgaris and Normal Individuals [J], The Chinese Journal of Dermatovenereology, 2008, 22 (11): 644-646. |
[13] | Schweitzer A, Horn J, Mikolajczyk RT, et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 [J]. Lancet Lond Engl, 2015, 386 (10003): 1546-1555. |
[14] | Kuhns MC, Holzmayer V, McNamara AL, et al. Improved detection of early acute, late acute, and occult Hepatitis B infections by an increased sensitivity HBsAg assay [J]. J Clin Virol, 2019, 118: 41-45. |
[15] | Chen P, Xie Q, Lu X, et al. Serum HBeAg and HBV DNA levels are not always proportional and only high levels of HBeAg most likely correlate with high levels of HBV DNA: A community-based study [J]. Medicine (Baltimore), 2017, 96 (33): e7766. |
[16] | Ming Y. Relationship between hepatitis B virus infection and metabolic syndrome [J], Journal of Chinese Practical Diagnosis and Therapy, 2017, 96 (33): e7766. |
[17] | Suiter C, Singha SK, Khalili R, et al. Free fatty acids: circulating contributors of metabolic syndrome [J]. Cardiovasc Hematol Agents Med Chem, 2018, 16 (1): 20-34. |
[18] | Wu YL, Peng XE, Zhu YB, et al. Hepatitis B virus X protein induces hepatic steatosis by enhancing the expression of liver fatty acid binding protein [J]. J Virol, 2015, 90 (4): 1729-1740. |
[19] | Li N, Yue H, Jia M, et al. Effect of low-ratio n-6/n-3 PUFA on blood glucose: a meta-analysis [J]. Food Funct, 2019, 10 (8): 4557-4565. |
[20] | Hodge AM, Simpson JA, Gibson RA, et al. Plasma phospholipid fatty acid composition as a biomarker of habitual dietary fat intake in an ethnically diverse cohort [J]. Nutr Metab Cardiovasc Dis, 2007, 17 (6): 415-426. |
[21] | Lee JG, Lee S, Kim YJ, et al. Association of chronic viral hepatitis B with insulin resistance [J]. World J Gastroenterol, 2012, 18 (42): 6120-6126. |
[22] | Kim K, Kim KH, Cheong J. Hepatitis B virus X protein impairs hepatic insulin signaling through degradation of IRS1 and induction of SOCS3 [J]. PLoS One, 2010, 5 (3): e8649. |
[23] | Zhu H, Wang Y, Yu L, et al. Serological and molecular analysis on the relationships between type 2 diabetes mellitus and hepatitis B virus infection [J]. J Infect Dev Ctries, 2016, 10 (8): 837-844. |
[24] | Xiao X, Liu J, Luo X. Serum phospholipid fatty acid and insulin resistance in patients with metabolic syndrome [J], Chinese Journal of Disease Control and Prevention, 2012, 16 (5): 388-391. |
[25] | Shen Y, Zhang J, Cai H, et al. Identifying patients with chronic hepatitis B at high risk of type 2 diabetes mellitus: a cross-sectional study with pair-matched controls [J]. BMC Gastroenterol. 2015, 32 (15): 1-8. |
APA Style
Li Ting, Chen Chan, Liu Yonggang, Yin Yan, Li Pin. (2021). Correlation Between HBV Infection Status, Level of Surface Antigen-antibody and Phospholipid Metabolism, Insulin Resistance. American Journal of Internal Medicine, 9(2), 91-95. https://doi.org/10.11648/j.ajim.20210902.17
ACS Style
Li Ting; Chen Chan; Liu Yonggang; Yin Yan; Li Pin. Correlation Between HBV Infection Status, Level of Surface Antigen-antibody and Phospholipid Metabolism, Insulin Resistance. Am. J. Intern. Med. 2021, 9(2), 91-95. doi: 10.11648/j.ajim.20210902.17
AMA Style
Li Ting, Chen Chan, Liu Yonggang, Yin Yan, Li Pin. Correlation Between HBV Infection Status, Level of Surface Antigen-antibody and Phospholipid Metabolism, Insulin Resistance. Am J Intern Med. 2021;9(2):91-95. doi: 10.11648/j.ajim.20210902.17
@article{10.11648/j.ajim.20210902.17, author = {Li Ting and Chen Chan and Liu Yonggang and Yin Yan and Li Pin}, title = {Correlation Between HBV Infection Status, Level of Surface Antigen-antibody and Phospholipid Metabolism, Insulin Resistance}, journal = {American Journal of Internal Medicine}, volume = {9}, number = {2}, pages = {91-95}, doi = {10.11648/j.ajim.20210902.17}, url = {https://doi.org/10.11648/j.ajim.20210902.17}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajim.20210902.17}, abstract = {Background: Chronic HBV infection has a continuous effect on blood sugar and blood phospholipid metabolism. Metabolic syndrome (MS) and insulin resistance (IR) are the main risk factor leading to diabetes and cardiovascular disease. At present, the relationship between chronic HBV infection and MS was still controversial. Objective: To explore the correlation between hepatitis B virus (HBV) infection status, level of surface antigen-antibody and phospholipid metabolism, insulin resistance (IR). Methods: A retrospective analysis was performed on the clinical data of 423 patients who underwent hepatitis B markers test in the hospital from January 2017 to June 2019. Among them, there were 95 cases with positive hepatitis B surface antigen (HBsAg) in the HBV infection positive group and 328 cases with negative HBsAg in the HBV infection negative group. The serum phospholipid fatty acid maps and IR related indexes were compared between the two groups. The correlation between the level of HBsAg antibody and phospholipid fatty acid maps, IR related indexes were analyzed by Spearman analysis. Results: The levels of saturated fatty acid (SFA) and u-6/u-3 polyunsaturated fatty acid (PUFA) in the HBV infection positive group were higher than those in the HBV infection negative group, while n-6PUFA, n-3PUFA, PUFA, and PUFA/SFA were all lower than those in HBV infection negative group (PPr=0.381, 0.369, 0.516, 0.453, Pr=-0.322, -0.306, -0.467, -0.482, -0.465, -0.356, PConclusion: HBV infection may cause changes in the composition of serum phospholipid fatty acid and IR.}, year = {2021} }
TY - JOUR T1 - Correlation Between HBV Infection Status, Level of Surface Antigen-antibody and Phospholipid Metabolism, Insulin Resistance AU - Li Ting AU - Chen Chan AU - Liu Yonggang AU - Yin Yan AU - Li Pin Y1 - 2021/03/26 PY - 2021 N1 - https://doi.org/10.11648/j.ajim.20210902.17 DO - 10.11648/j.ajim.20210902.17 T2 - American Journal of Internal Medicine JF - American Journal of Internal Medicine JO - American Journal of Internal Medicine SP - 91 EP - 95 PB - Science Publishing Group SN - 2330-4324 UR - https://doi.org/10.11648/j.ajim.20210902.17 AB - Background: Chronic HBV infection has a continuous effect on blood sugar and blood phospholipid metabolism. Metabolic syndrome (MS) and insulin resistance (IR) are the main risk factor leading to diabetes and cardiovascular disease. At present, the relationship between chronic HBV infection and MS was still controversial. Objective: To explore the correlation between hepatitis B virus (HBV) infection status, level of surface antigen-antibody and phospholipid metabolism, insulin resistance (IR). Methods: A retrospective analysis was performed on the clinical data of 423 patients who underwent hepatitis B markers test in the hospital from January 2017 to June 2019. Among them, there were 95 cases with positive hepatitis B surface antigen (HBsAg) in the HBV infection positive group and 328 cases with negative HBsAg in the HBV infection negative group. The serum phospholipid fatty acid maps and IR related indexes were compared between the two groups. The correlation between the level of HBsAg antibody and phospholipid fatty acid maps, IR related indexes were analyzed by Spearman analysis. Results: The levels of saturated fatty acid (SFA) and u-6/u-3 polyunsaturated fatty acid (PUFA) in the HBV infection positive group were higher than those in the HBV infection negative group, while n-6PUFA, n-3PUFA, PUFA, and PUFA/SFA were all lower than those in HBV infection negative group (PPr=0.381, 0.369, 0.516, 0.453, Pr=-0.322, -0.306, -0.467, -0.482, -0.465, -0.356, PConclusion: HBV infection may cause changes in the composition of serum phospholipid fatty acid and IR. VL - 9 IS - 2 ER -